ANI Pharmaceuticals: Q4 Earnings Insights

ANI Pharmaceuticals ANIP reported its Q4 earnings results on Tuesday, March 15, 2022 at 06:50 AM.

Here's what investors need to know about the announcement.

ANI Pharmaceuticals missed estimated earnings by 27.03%, reporting an EPS of $0.54 versus an estimate of $0.74.

Revenue was up $3.68 million from the same period last year.

Last quarter the company beat on EPS by $0.31 which was followed by a 1.72% increase in the share price the next day.

Here's a look at ANI Pharmaceuticals's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	0.70	0.68	0.71	0.94
EPS Actual	1.01	0.67	1.04	0.80
Revenue Estimate	49.70M	48.05M	46.80M	54.27M
Revenue Actual	52.06M	48.62M	54.52M	57.25M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar